What weve seen is that people taking GLP-1 medications need help with a different set of behavioral challenges in comparison to people not on these medications, said Gary Foster, PhD, Chief Scientific Officer, WeightWatchers in a statement
[2] However, scientific evidence is still insufficient and focus on several modalities while CAM has a wide variety, which drives this research
Zielsdorf has found that her thyroid patients, post RAI and post-thyroidectomy, often need different dosing and medication protocols compared to the average person, but, unfortunately, many physicians are not aware of this
Under end-stage capitalism, being a patient implies helplessness and a lack of agency, the humiliation of being taken advantage of